Form 4: Standex CFO Sells Shares Under Pre-Arranged Plan
Insider Transaction Report
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,085 shares of common stock for approximately $209.86 per share on August 26, 2025, under a Rule 10b5-1 plan.
Summary
- Ademir Sarcevic, Vice President, CFO, and Treasurer of Standex International Corp/DE/ (SXI), reported a sale of common stock.
- The transaction involved the disposition of 1,085 shares of common stock.
- The shares were sold on August 26, 2025, at a weighted average price of $209.8642 per share.
- The sales occurred in multiple transactions with prices ranging from $209.175 to $210.41.
- Following this transaction, Mr. Sarcevic beneficially owns 11,164 shares of Standex International common stock directly.
- The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 5
Explanation: Neutral. While insider selling can be viewed cautiously, the transaction was pre-arranged under a 10b5-1 plan, mitigating negative interpretations. The executive also retains a substantial holding.
Positives
- The sale was conducted under a Rule 10b5-1(c) plan, indicating it was pre-arranged and not based on immediate, non-public information.
- Ademir Sarcevic retains a significant beneficial ownership of 11,164 shares after the transaction, maintaining alignment with shareholder interests.
Negatives
- Insider selling, even under a pre-arranged plan, reduces the direct equity stake of a key executive.
Future Outlook
Not applicable, as this filing reports a past insider transaction and does not provide forward-looking statements or guidance.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitor analysis.
Stakeholder Impact
- Shareholders: May interpret the sale as a minor signal, though the 10b5-1 plan and retained holdings temper any significant concern.
Key Dates
| Date | Description |
|---|---|
| 08/26/2025 | Date of earliest transaction (sale of common stock) |
| 08/28/2025 | Date the Form 4 was filed |
Recommendation
holdThe sale of shares by a key executive, even under a pre-arranged 10b5-1 plan, is a data point for investors. While it reduces the executive's direct equity exposure, the remaining substantial holding of 11,164 shares suggests continued alignment. This single transaction, without further context on company performance or broader market conditions, does not warrant a change from a 'hold' recommendation.
Keywords
Standex International, SXI, Ademir Sarcevic, Form 4, Insider Trading, Stock Sale, CFO, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.